# 2026-04546: FDA Axes 46 Zombie Drugs: No Sales, No Approval Anymore

2026-04546, Aspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-03-09, effective 2026-04-08; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04546
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04546
- Title: Aspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 11321
- Published: 2026-03-09
- Effective: 2026-04-08
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Axes 46 Zombie Drugs: No Sales, No Approval Anymore

## Summary

The FDA is officially pulling the plug on 46 drug approvals because the companies told them these medicines aren’t being sold anymore. This change kicks in on April 8, 2026, and it affects drugs from Aspen Global Inc. and others. No money penalties here—just a clean break, but companies can ask to reapply if they want to bring the drugs back.

## Abstract

The Food and Drug Administration (FDA or Agency) is withdrawing approval of 46 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.

## Effects PRIA read

- 46 Drug Approvals Withdrawn April 8, 2026: cost, medium. The FDA withdrew approval of 46 new drug applications (NDAs) as of April 8, 2026 because the applicants told the Agency the products are no longer marketed. If you use any of the listed drugs, those specific approved products are formally no longer approved after April 8, 2026.
- Existing Inventory Can Still Be Dispensed: benefit, low. Drug products listed in the notice that are in inventory on April 8, 2026 may continue to be dispensed until those inventories are depleted or the products reach their expiration dates, whichever happens first. This means pharmacies and patients may still get these specific drug products for a limi…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-04546 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/09/2026-04546/aspen-global-inc-co-lachman-consultant-services-inc-et-al-withdrawal-of-approval-of-46-new-drug)
- [2026-04546 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-09/pdf/2026-04546.pdf)

## Related
- [Previous: 2026-04545, Notice of Determinations; Additional Culturally Significant Object Being Import…](https://policyrisk.com/federal-register/2026-04545)
- [Next: 2026-04547, Submission for Review: 3206-0194, Annuity Supplement Earnings Report, RI 92-22](https://policyrisk.com/federal-register/2026-04547)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04546 (as of 2026-06-08).
